부산대학교 도서관

Lou, Jieqiong; Deng, Qiji; Zhang, Xiaomeng; Bell, Charles C; Das, Andrew B; Bediaga, Naiara G; Zlatic, Courtney O; Johanson, Timothy M; Allan, Rhys S; Griffin, Michael D W; Paradkar, PrasadN; Harvey, Kieran F; Dawson, Mark A; Hinde, Elizabeth

Nucleic Acids Research; 10/14/2024, Vol. 52 Issue 18, p10918-10933, 16p

Bell CC; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, QLD, 4102, Australia. charles.bell@mater.uq.edu.au.; Faulkner GJ; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, QLD, 4102, Australia.; Queensland Brain Institute, University of Queensland, Brisbane, QLD, 4169, Australia.; Gilan O; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, 3004, Australia.

Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100960660 Publication Model: Electronic Cited Medium: Internet ISSN: 1474-760X (Electronic) Linking ISSN: 14747596 NLM ISO Abbreviation: Genome Biol Subsets: MEDLINE

Bodea GO; Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia. gabriela.bodea@gmail.com.; Mater Research Institute - University of Queensland, TRI Building, Woolloongabba, Queensland, Australia. gabriela.bodea@gmail.com.; Botto JM; Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia.; Ferreiro ME; Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia.; Sanchez-Luque FJ; Institute of Parasitology and Biomedicine 'López-Neyra', Spanish National Research Council, Granada, Spain.; de Los Rios Barreda J; Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia.; Rasmussen J; Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia.; Rahman MA; Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia.; Fenlon LR; Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia.; Jansz N; Mater Research Institute - University of Queensland, TRI Building, Woolloongabba, Queensland, Australia.; Gubert C; Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia.; Gerdes P; Mater Research Institute - University of Queensland, TRI Building, Woolloongabba, Queensland, Australia.; Bodea LG; Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia.; Ajjikuttira P; Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia.; Da Costa Guevara DJ; Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia.; Mater Research Institute - University of Queensland, TRI Building, Woolloongabba, Queensland, Australia.; Cumner L; Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia.; Bell CC; Mater Research Institute - University of Queensland, TRI Building, Woolloongabba, Queensland, Australia.; Kozulin P; Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia.; Billon V; Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia.; Biology Department, École Normale Supérieure Paris-Saclay, Gif-sur-Yvette, France.; Morell S; Mater Research Institute - University of Queensland, TRI Building, Woolloongabba, Queensland, Australia.; Department of Genetics, University of Cambridge, Cambridge, UK.; Kempen MHC; MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital, Edinburgh, UK.; Love CJ; Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia.; Saha K; Department of Pharmaceutical Sciences, South Dakota State University, Brookings, SD, USA.; Palmer LM; Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia.; Florey Department of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia.; Ewing AD; Mater Research Institute - University of Queensland, TRI Building, Woolloongabba, Queensland, Australia.; Jhaveri DJ; Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia.; Mater Research Institute - University of Queensland, TRI Building, Woolloongabba, Queensland, Australia.; Richardson SR; Mater Research Institute - University of Queensland, TRI Building, Woolloongabba, Queensland, Australia.; Hannan AJ; Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia.; Faulkner GJ; Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia. faulknergj@gmail.com.; Mater Research Institute - University of Queensland, TRI Building, Woolloongabba, Queensland, Australia. faulknergj@gmail.com.

Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 9809671 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1726 (Electronic) Linking ISSN: 10976256 NLM ISO Abbreviation: Nat Neurosci Subsets: MEDLINE

Bell CC; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. charles.bell@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. charles.bell@petermac.org.; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, Queensland, Australia. charles.bell@petermac.org.; Balic JJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Talarmain L; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Gillespie A; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Scolamiero L; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Lam EYN; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Ang CS; Bio21 Mass Spectrometry and Proteomics Facility, The University of Melbourne, Parkville, Victoria, Australia.; Faulkner GJ; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, Queensland, Australia.; Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia.; Gilan O; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.; Dawson MA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. mark.dawson@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. mark.dawson@petermac.org.; Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. mark.dawson@petermac.org.; Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia. mark.dawson@petermac.org.

Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE

Gilan O; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. omer.gilan@monash.edu.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. omer.gilan@monash.edu.; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia. omer.gilan@monash.edu.; Talarmain L; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Bell CC; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Neville D; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.; Knezevic K; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Ferguson DT; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.; Boudes M; Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.; Chan YC; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Davidovich C; Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.; EMBL-Australia, Clayton, Victoria, Australia.; Lam EYN; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Dawson MA; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. mark.dawson@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. mark.dawson@petermac.org.; Department of Clinical Haematology, Peter MacCallum Cancer Centre & Royal Melbourne Hospital, Melbourne, Victoria, Australia. mark.dawson@petermac.org.; Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia. mark.dawson@petermac.org.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101186374 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-9985 (Electronic) Linking ISSN: 15459985 NLM ISO Abbreviation: Nat Struct Mol Biol Subsets: MEDLINE

Ng AP; Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia. ang@wehi.edu.au.; Department of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia. ang@wehi.edu.au.; Coughlan HD; Department of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia.; Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.; Hediyeh-Zadeh S; Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.; Behrens K; Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.; Johanson TM; Department of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia.; Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.; Low MSY; Department of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia.; Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.; Monash Haematology, Monash Hospital, Clayton, VIC, 3004, Australia.; Bell CC; Peter MacCallum Cancer Centre, Parkville, VIC, 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, 3010, Australia.; Gilan O; Peter MacCallum Cancer Centre, Parkville, VIC, 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, 3010, Australia.; Chan YC; Peter MacCallum Cancer Centre, Parkville, VIC, 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, 3010, Australia.; Kueh AJ; Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia.; Boudier T; Department of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia.; Advanced Technology and Biology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.; Feltham R; Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3010, Australia.; Gabrielyan A; Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3010, Australia.; DiRago L; Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.; Hyland CD; Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.; Ierino H; Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.; Mifsud S; Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.; Viney E; Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.; Willson T; Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.; Dawson MA; Peter MacCallum Cancer Centre, Parkville, VIC, 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, 3010, Australia.; Centre for Cancer Research, The University of Melbourne, Parkville, VIC, 3010, Australia.; Allan RS; Department of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia.; Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.; Herold MJ; Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia.; Rogers K; Department of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia.; Advanced Technology and Biology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.; Tarlinton DM; Department of Immunology and Pathology, Monash University, Melbourne, VIC, 3004, Australia.; Smyth GK; Department of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia.; Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.; Davis MJ; Department of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia.; Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.; Nutt SL; Department of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia.; Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.; Alexander WS; Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Bell CC; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Fennell KA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Chan YC; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Rambow F; Laboratory for Molecular Cancer Biology, VIB Center for Cancer Biology, KU Leuven, Leuven, Belgium.; Yeung MM; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Vassiliadis D; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Lara L; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Yeh P; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Martelotto LG; Centre for Cancer Research, University of Melbourne, Melbourne, VIC, Australia.; Rogiers A; Laboratory for Molecular Cancer Biology, VIB Center for Cancer Biology, KU Leuven, Leuven, Belgium.; Department of Oncology, KU Leuven, Leuven, Belgium.; Kremer BE; Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA.; Barbash O; Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA.; Mohammad HP; Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA.; Johanson TM; The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; The Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia.; Burr ML; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Dhar A; Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA.; Karpinich N; Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA.; Tian L; The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; The Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia.; Tyler DS; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; MacPherson L; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Shi J; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.; Pinnawala N; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Yew Fong C; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Papenfuss AT; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; The Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia.; Grimmond SM; Centre for Cancer Research, University of Melbourne, Melbourne, VIC, Australia.; Dawson SJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Centre for Cancer Research, University of Melbourne, Melbourne, VIC, Australia.; Allan RS; The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; The Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia.; Kruger RG; Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA.; Vakoc CR; Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA.; Goode DL; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Naik SH; The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; The Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia.; Gilan O; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Lam EYN; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Marine JC; Laboratory for Molecular Cancer Biology, VIB Center for Cancer Biology, KU Leuven, Leuven, Belgium.; Department of Oncology, KU Leuven, Leuven, Belgium.; Prinjha RK; Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA.; Dawson MA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. Mark.Dawson@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia. Mark.Dawson@petermac.org.; Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. Mark.Dawson@petermac.org.; Centre for Cancer Research, University of Melbourne, Melbourne, VIC, Australia. Mark.Dawson@petermac.org.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Sparbier CE; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Gillespie A; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Gomez J; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; The John Curtin School of Medical Research, The Australian National University, Canberra, Australian Capital Territory, Australia.; Kumari N; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Motazedian A; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Chan KL; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Bell CC; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Gilan O; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.; Chan YC; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Popp S; The John Curtin School of Medical Research, The Australian National University, Canberra, Australian Capital Territory, Australia.; Gough DJ; Department of Molecular Translational Science, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Eckersley-Maslin MA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Department of Anatomy and Physiology, University of Melbourne, Melbourne, Victoria, Australia.; Dawson SJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia.; Lehner PJ; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Sutherland KD; ACRF Cancer Biology and Stem Cells Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.; Ernst P; Section of Hematology, Oncology and Bone Marrow Transplant, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; McGeehan GM; Syndax Pharmaceuticals, Waltham, MA, USA.; Lam EYN; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Burr ML; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. marian.burr@anu.edu.au.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. marian.burr@anu.edu.au.; The John Curtin School of Medical Research, The Australian National University, Canberra, Australian Capital Territory, Australia. marian.burr@anu.edu.au.; Department of Anatomical Pathology, ACT Pathology, Canberra Health Services, Canberra, Australian Capital Territory, Australia. marian.burr@anu.edu.au.; Dawson MA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. mark.dawson@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. mark.dawson@petermac.org.; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia. mark.dawson@petermac.org.; Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia. mark.dawson@petermac.org.

Publisher: Macmillan Magazines Ltd Country of Publication: England NLM ID: 100890575 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4679 (Electronic) Linking ISSN: 14657392 NLM ISO Abbreviation: Nat Cell Biol Subsets: MEDLINE

Bell, Charles C; Magor, Graham W; Gillinder, Kevin R; Perkins, Andrew C

BMC Genomics. November 20, 2014, Vol. 15

Gillinder KR; Cancer Genomics Group, Mater Research Institute - University of Queensland, Translational Research Institute, Woolloongabba, Brisbane, Queensland, Australia.; Tuckey H; Cancer Genomics Group, Mater Research Institute - University of Queensland, Translational Research Institute, Woolloongabba, Brisbane, Queensland, Australia.; Faculty of Medicine and Biomedical Sciences, University of Queensland, St. Lucia, Brisbane, Queensland, Australia.; Bell CC; Cancer Genomics Group, Mater Research Institute - University of Queensland, Translational Research Institute, Woolloongabba, Brisbane, Queensland, Australia.; Magor GW; Cancer Genomics Group, Mater Research Institute - University of Queensland, Translational Research Institute, Woolloongabba, Brisbane, Queensland, Australia.; Huang S; Cancer Genomics Group, Mater Research Institute - University of Queensland, Translational Research Institute, Woolloongabba, Brisbane, Queensland, Australia.; Faculty of Medicine and Biomedical Sciences, University of Queensland, St. Lucia, Brisbane, Queensland, Australia.; Ilsley MD; Cancer Genomics Group, Mater Research Institute - University of Queensland, Translational Research Institute, Woolloongabba, Brisbane, Queensland, Australia.; Faculty of Medicine and Biomedical Sciences, University of Queensland, St. Lucia, Brisbane, Queensland, Australia.; Perkins AC; Cancer Genomics Group, Mater Research Institute - University of Queensland, Translational Research Institute, Woolloongabba, Brisbane, Queensland, Australia.; Faculty of Medicine and Biomedical Sciences, University of Queensland, St. Lucia, Brisbane, Queensland, Australia.; Princess Alexandra Hospital, Brisbane, Queensland, Australia.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Tyler DS; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Vappiani J; Cellzome GmbH, GlaxoSmithKline, Meyerhofstrasse 1, Heidelberg, Germany.; Cañeque T; Chemical Cell Biology Group, Institut Curie, Paris Sciences et Lettres Research University, 26 Rue d'Ulm, 75248 Paris Cedex 05, France.; CNRS UMR3666, 75005 Paris, France.; INSERM U1143, 75005 Paris, France.; Lam EYN; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Ward A; Cellzome GmbH, GlaxoSmithKline, Meyerhofstrasse 1, Heidelberg, Germany.; Gilan O; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Chan YC; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Hienzsch A; Chemical Cell Biology Group, Institut Curie, Paris Sciences et Lettres Research University, 26 Rue d'Ulm, 75248 Paris Cedex 05, France.; CNRS UMR3666, 75005 Paris, France.; INSERM U1143, 75005 Paris, France.; Rutkowska A; Cellzome GmbH, GlaxoSmithKline, Meyerhofstrasse 1, Heidelberg, Germany.; Werner T; Cellzome GmbH, GlaxoSmithKline, Meyerhofstrasse 1, Heidelberg, Germany.; Wagner AJ; Cellzome GmbH, GlaxoSmithKline, Meyerhofstrasse 1, Heidelberg, Germany.; Lugo D; Epigenetics Discovery Performance Unit, Immuno-Inflammation Therapy Area Unit, GlaxoSmithKline, Stevenage, UK.; Gregory R; Epigenetics Discovery Performance Unit, Immuno-Inflammation Therapy Area Unit, GlaxoSmithKline, Stevenage, UK.; Ramirez Molina C; Epigenetics Discovery Performance Unit, Immuno-Inflammation Therapy Area Unit, GlaxoSmithKline, Stevenage, UK.; Garton N; Epigenetics Discovery Performance Unit, Immuno-Inflammation Therapy Area Unit, GlaxoSmithKline, Stevenage, UK.; Wellaway CR; Epigenetics Discovery Performance Unit, Immuno-Inflammation Therapy Area Unit, GlaxoSmithKline, Stevenage, UK.; Jackson S; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; MacPherson L; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Figueiredo M; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Stolzenburg S; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Bell CC; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; House C; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Dawson SJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia.; Hawkins ED; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Drewes G; Cellzome GmbH, GlaxoSmithKline, Meyerhofstrasse 1, Heidelberg, Germany.; Prinjha RK; Epigenetics Discovery Performance Unit, Immuno-Inflammation Therapy Area Unit, GlaxoSmithKline, Stevenage, UK.; Rodriguez R; Chemical Cell Biology Group, Institut Curie, Paris Sciences et Lettres Research University, 26 Rue d'Ulm, 75248 Paris Cedex 05, France.; CNRS UMR3666, 75005 Paris, France.; INSERM U1143, 75005 Paris, France.; Grandi P; Cellzome GmbH, GlaxoSmithKline, Meyerhofstrasse 1, Heidelberg, Germany. paola.x.grandi@gsk.com mark.dawson@petermac.org.; Dawson MA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. paola.x.grandi@gsk.com mark.dawson@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia.; Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE

Watt AC; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Cejas P; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Translational Oncology Laboratory, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.; CIBERONC CB16/12/00398, La Paz University Hospital, Madrid, Spain.; DeCristo MJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Metzger-Filho O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Lam EYN; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Qiu X; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; BrinJones H; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Kesten N; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Coulson R; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Font-Tello A; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Lim K; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Vadhi R; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Daniels VW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Montero J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Institute for Bioengineering of Catalonia, Barcelona, Spain.; Taing L; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Meyer CA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Gilan O; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Bell CC; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Korthauer KD; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Giambartolomei C; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.; Istituto Italiano di Tecnologia (IIT), Genoa, Italy.; Pasaniuc B; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.; Seo JH; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Freedman ML; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Ma C; Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA.; Ellis MJ; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA.; Krop I; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Winer E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Brown M; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Dawson MA; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Centre for Cancer Research, University of Melbourne, Parkville, Victoria, Australia.; Long HW; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. Henry_Long@dfci.harvard.edu.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Henry_Long@dfci.harvard.edu.; Zhao JJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. Jean_Zhao@dfci.harvard.edu.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. Jean_Zhao@dfci.harvard.edu.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA. Jean_Zhao@dfci.harvard.edu.; Goel S; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. shom.goel@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia. shom.goel@petermac.org.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. shom.goel@petermac.org.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer

Watt, April C; Cejas, Paloma; DeCristo, Molly; Metzger, Otto; Lam, Enid; Qiu, Xintao; BrinJones, Haley; Kesten, Nikolas; Coulson, Rhiannon; Alba, Font-Tello; Lim, Klothilda; Vadhi, Raga; Daniels, Veerle W; Montero, Joan; Taing, Len; Meyer, Clifford; Gilan, Omer; Bell, Charles C; Korthauer, Keegan; Giambartolomei, Claudia; Pasaniuc, Bogdan; Seo, Ji-Heui; Freedman, Matthew L; Ma, Cynthia; Ellis, Matthew J; Krop, Ian; Winer, Eric; Letai, Anthony; Brown, Myles; Dawson, Mark A; Long, Henry W; Zhao, Jean; Goel, Shom

Watt, April C, Paloma Cejas, Molly DeCristo, Otto Metzger, Enid Lam, Xintao Qiu, Haley BrinJones et al. "CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity." Nat Cancer 2, no. 1 (2020): 34-48. DOI: 10.1038/s43018-020-00135-y

Bell CC; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. charles.bell@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia. charles.bell@petermac.org.; Gilan O; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.

Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

Fennell KA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology and.; Bell CC; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology and.; Dawson MA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology and.; Centre for Cancer Research, University of Melbourne, Melbourne, VIC, Australia; and.; Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Burr ML; Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3052, Australia; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0XY, UK. Electronic address: marian.burr@petermac.org.; Sparbier CE; Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3052, Australia.; Chan KL; Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3052, Australia.; Chan YC; Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC 3000, Australia.; Kersbergen A; ACRF Cancer Biology and Stem Cell Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.; Lam EYN; Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3052, Australia.; Azidis-Yates E; Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC 3000, Australia.; Vassiliadis D; Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3052, Australia.; Bell CC; Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3052, Australia.; Gilan O; Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3052, Australia.; Jackson S; Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC 3000, Australia.; Tan L; Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3052, Australia.; Wong SQ; Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3052, Australia.; Hollizeck S; Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3052, Australia.; Michalak EM; Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3052, Australia.; Siddle HV; Department of Biological Sciences, University of Southampton, Southampton, UK; Institute for Life Sciences, University of Southampton, Southampton, UK.; McCabe MT; Epigenetics Research Unit, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.; Prinjha RK; Epigenetics Research Unit, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA; Epigenetics Research Unit, GlaxoSmithKline, Stevenage, UK.; Guerra GR; Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3052, Australia.; Solomon BJ; Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3052, Australia.; Sandhu S; Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3052, Australia.; Dawson SJ; Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3052, Australia; Centre for Cancer Research, University of Melbourne, Parkville, Australia.; Beavis PA; Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3052, Australia.; Tothill RW; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3052, Australia; Centre for Cancer Research, University of Melbourne, Parkville, Australia; Department of Clinical Pathology, University of Melbourne, Melbourne, VIC, Australia.; Cullinane C; Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3052, Australia.; Lehner PJ; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0XY, UK.; Sutherland KD; ACRF Cancer Biology and Stem Cell Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Parkville, VIC 3010, Australia.; Dawson MA; Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3052, Australia; Centre for Cancer Research, University of Melbourne, Parkville, Australia. Electronic address: mark.dawson@petermac.org.

Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

McKenzie MD; Molecular Medicine Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia.; Ghisi M; Australian Centre for Blood Diseases, Monash University, Commercial Road, Melbourne, VIC 3004, Australia.; Oxley EP; Australian Centre for Blood Diseases, Monash University, Commercial Road, Melbourne, VIC 3004, Australia.; Ngo S; Australian Centre for Blood Diseases, Monash University, Commercial Road, Melbourne, VIC 3004, Australia.; Cimmino L; Department of Pathology, New York University School of Medicine, 550 1(st) Avenue, New York, NY 10016, USA.; Esnault C; Collège de France, PSL Research University, 75005 Paris, France; INSERM U944, CNRS UMR7212, Université de Paris, Institut de Recherche Saint Louis, 75010 Paris, France; Assistance Publique/Hôpitaux de Paris, Oncologie Moléculaire, Hôpital St. Louis, 75010 Paris, France.; Liu R; Molecular Medicine Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia.; Salmon JM; Australian Centre for Blood Diseases, Monash University, Commercial Road, Melbourne, VIC 3004, Australia.; Bell CC; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia.; Ahmed N; Department of Biosystems Science and Engineering, ETH Zurich, Mattenstrasse 26, 4058 Basel, Switzerland.; Erlichster M; Molecular Medicine Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville, VIC 3010, Australia.; Witkowski MT; Molecular Medicine Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia; Australian Centre for Blood Diseases, Monash University, Commercial Road, Melbourne, VIC 3004, Australia; Department of Pathology, New York University School of Medicine, 550 1(st) Avenue, New York, NY 10016, USA; Department of Medical Biology, University of Melbourne, Parkville, VIC 3010, Australia.; Liu GJ; Molecular Medicine Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia; Australian Centre for Blood Diseases, Monash University, Commercial Road, Melbourne, VIC 3004, Australia; Department of Medical Biology, University of Melbourne, Parkville, VIC 3010, Australia.; Chopin M; Molecular Immunology Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia.; Dakic A; Molecular Immunology Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia.; Simankowicz E; Australian Centre for Blood Diseases, Monash University, Commercial Road, Melbourne, VIC 3004, Australia.; Pomilio G; Australian Centre for Blood Diseases, Monash University, Commercial Road, Melbourne, VIC 3004, Australia; Department of Clinical Haematology, The Alfred Hospital, Melbourne, VIC 3004, Australia.; Vu T; Australian Centre for Blood Diseases, Monash University, Commercial Road, Melbourne, VIC 3004, Australia.; Krsmanovic P; Institute of Pathological Physiology and Biocev, First Faculty of Medicine, Charles University, Prague, Czech Republic.; Su S; Molecular Medicine Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia.; Tian L; Molecular Medicine Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville, VIC 3010, Australia.; Baldwin TM; Molecular Medicine Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia.; Zalcenstein DA; Molecular Medicine Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia.; DiRago L; Cancer and Haematology Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia.; Wang S; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.; Metcalf D; Department of Medical Biology, University of Melbourne, Parkville, VIC 3010, Australia; Cancer and Haematology Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia.; Johnstone RW; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia.; Croker BA; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.; Lancaster GI; Baker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia; Department of Immunology and Pathology, Monash University, Commercial Road, Melbourne, VIC 3004, Australia.; Murphy AJ; Baker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia; Department of Immunology and Pathology, Monash University, Commercial Road, Melbourne, VIC 3004, Australia.; Naik SH; Molecular Medicine Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville, VIC 3010, Australia.; Nutt SL; Department of Medical Biology, University of Melbourne, Parkville, VIC 3010, Australia; Molecular Immunology Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia.; Pospisil V; Institute of Pathological Physiology and Biocev, First Faculty of Medicine, Charles University, Prague, Czech Republic.; Schroeder T; Department of Biosystems Science and Engineering, ETH Zurich, Mattenstrasse 26, 4058 Basel, Switzerland.; Wall M; Department of Medical Biology, University of Melbourne, Parkville, VIC 3010, Australia; Victorian Cancer Cytogenetics Service, St. Vincent's Hospital, 41 Victoria Parade, Fitzroy, VIC 3065, Australia.; Dawson MA; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia.; Wei AH; Australian Centre for Blood Diseases, Monash University, Commercial Road, Melbourne, VIC 3004, Australia; Department of Clinical Haematology, The Alfred Hospital, Melbourne, VIC 3004, Australia.; de Thé H; Collège de France, PSL Research University, 75005 Paris, France; INSERM U944, CNRS UMR7212, Université de Paris, Institut de Recherche Saint Louis, 75010 Paris, France; Assistance Publique/Hôpitaux de Paris, Oncologie Moléculaire, Hôpital St. Louis, 75010 Paris, France.; Ritchie ME; Molecular Medicine Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville, VIC 3010, Australia; School of Mathematics and Statistics, University of Melbourne, Parkville, VIC 3010, Australia.; Zuber J; Research Institute of Molecular Pathology, Campus Vienna Biocenter 1, 1030 Vienna, Austria; Medical University of Vienna, 1030 Vienna, Austria.; Dickins RA; Australian Centre for Blood Diseases, Monash University, Commercial Road, Melbourne, VIC 3004, Australia. Electronic address: ross.dickins@monash.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 101311472 Publication Model: Print Cited Medium: Internet ISSN: 1875-9777 (Electronic) Linking ISSN: 18759777 NLM ISO Abbreviation: Cell Stem Cell Subsets: MEDLINE

Agarwal R; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Chan YC; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Tam CS; Department of Haematology, Royal Melbourne Hospital & Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Haematology, St. Vincent's Hospital, Melbourne, Victoria, Australia.; Department of Medicine, St. Vincent's Hospital, Melbourne, Victoria, Australia.; Hunter T; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Vassiliadis D; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Teh CE; Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia.; Thijssen R; Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia.; Yeh P; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Department of Haematology, Royal Melbourne Hospital & Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Wong SQ; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Ftouni S; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Lam EYN; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Anderson MA; Department of Haematology, Royal Melbourne Hospital & Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia.; Pott C; University Hospital of Schleswig-Holstein, Kiel, Germany.; Gilan O; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Bell CC; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Knezevic K; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Blombery P; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Haematology, Royal Melbourne Hospital & Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Rayeroux K; Victorian Cancer Cytogenetics Service, Melbourne, Victoria, Australia.; Zordan A; Victorian Cancer Cytogenetics Service, Melbourne, Victoria, Australia.; Li J; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Huang DCS; Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia.; Wall M; Department of Medicine, St. Vincent's Hospital, Melbourne, Victoria, Australia.; Victorian Cancer Cytogenetics Service, Melbourne, Victoria, Australia.; St. Vincent's Institute of Medical Research, Melbourne, Victoria, Australia.; Seymour JF; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Department of Haematology, Royal Melbourne Hospital & Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Gray DHD; Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia.; Roberts AW; Department of Haematology, Royal Melbourne Hospital & Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia.; Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia.; Dawson MA; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. mark.dawson@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. mark.dawson@petermac.org.; Department of Haematology, Royal Melbourne Hospital & Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. mark.dawson@petermac.org.; Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia. mark.dawson@petermac.org.; Dawson SJ; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. sarah-jane.dawson@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. sarah-jane.dawson@petermac.org.; Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia. sarah-jane.dawson@petermac.org.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Bell CC; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, VIC 3052, Australia.; Dawson MA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, VIC 3052, Australia; Centre for Cancer Research, University of Melbourne, Melbourne, VIC, Australia; Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia. Electronic address: mark.dawson@petermac.org.

Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

Burr ML; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3052, Australia.; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0XY, UK.; Sparbier CE; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Chan YC; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Williamson JC; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0XY, UK.; Woods K; School of Cancer Medicine, La Trobe University, Melbourne, Victoria 3086, Australia.; Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria 3084, Australia.; Beavis PA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3052, Australia.; Lam EYN; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3052, Australia.; Henderson MA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3052, Australia.; Bell CC; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3052, Australia.; Stolzenburg S; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Gilan O; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3052, Australia.; Bloor S; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0XY, UK.; Noori T; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Morgens DW; Department of Genetics, Stanford University, Stanford, California, USA.; Bassik MC; Department of Genetics, Stanford University, Stanford, California, USA.; Neeson PJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3052, Australia.; Behren A; School of Cancer Medicine, La Trobe University, Melbourne, Victoria 3086, Australia.; Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria 3084, Australia.; Darcy PK; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3052, Australia.; Dawson SJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3052, Australia.; Centre for Cancer Research, University of Melbourne, Melbourne, Australia.; Voskoboinik I; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3052, Australia.; Trapani JA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3052, Australia.; Cebon J; School of Cancer Medicine, La Trobe University, Melbourne, Victoria 3086, Australia.; Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria 3084, Australia.; Lehner PJ; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0XY, UK.; Dawson MA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3052, Australia.; Centre for Cancer Research, University of Melbourne, Melbourne, Australia.; Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE